It’s time for a listener favorite, the annual Inside Workers’ Comp Thanksgiving special edition: What are You Thankful for in Workers’ Comp? This year, we pose the question to experts who serve three very different facets of the industry: Jim Harris, VP of Analytics and Reporting; Debbi Bromley, Senior VP of Human Resources; and Lisa Armstrong, BSN, CRRN, RN-BC, Catastrophic and Medical Case Manager. We hope their responses lead you to contemplate on your own unique role in workers’ comp and how YOU make a difference in the lives of others.
More stories
Current Used Vehicle Market Conditions: Q2 2020
Building on a May rebound, wholesale prices in June rose by nearly 10% month-over-month.
Cracking the Code: What DTCs Tell Us About Vehicle Repair Trends
Diagnostic scanning has become a critical first—and last—step in the repair process. While mechanics have long relied on it to identify emission system malfunctions, collision repairers are now more routinely performing pre- and post-scans.
At the eye of the storm: An opioid overdose epidemic and a viral pandemic converge
s 2020 opened, a persistent and tragic opioid overdose epidemic was near the front of a list of national concerns in the US. Some 20+ million Americans are reported to have a substance use disorder and 2M of those misuse opioids.
Is Your Workplace Safe2Work?
As employers are looking for efficient ways to keep work environments safe from COVID-19, Optis has developed Safe2Work, an app-enabled, web-based
Quality Control in Clinical, Interview with Sharon Riley
We interviewed Sharon Riley, Director of Service Operations for Field Case Management, Coventry about best practices for quality assurance within a clinical case management program. Read on for her insightful responses.
Opioid Risk Mitigation: Medication-Assisted Treatment (MAT) and Naloxone
This week in our in-depth review of our Coventry Drug Trends series, part three, we focus on opioid risk mitigation strategies. While opioids continue to decline in workers’ compensation as both a percentage of total script volume and costs, it remains vital to promote evidence-based strategies such as MAT and naloxone to curb opioid issues.